Skip to main content

Biocept Selector Liquid Biopsy for Non-Small Cell Lung Cancer

Biocept announced it has launched a blood-based EGFR mutation test for non-small cell lung cancer patients based on its Selector technology platform. Screening circulating tumor cells and DNA, the assay targets a region of the gene that includes T790M, a biomarker that identifies therapy-resistant tumors. This test will be performed at the firm's CLIA-certified and CAP-accredited laboratory.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.